Related news from
Fri, 12 Dec 2025 17:10:18 +0000	Cencora’s Expanded Cold Chain and 3PL Network Might Change The Case For Investing In Cencora (COR) Cencora recently announced it has expanded its global third-party logistics capabilities by acquiring NextPharma Logistics in Germany, Austria and Switzerland, investing in additional cold chain capacity across Europe, and committing to a new highly automated 500,000 square-foot 3PL facility in Texas expected to be operational in 2028. This build-out of temperature-controlled and cryogenic infrastructure deepens Cencora’s role in handling complex specialty medicines, positioning its...
Fri, 12 Dec 2025 15:11:22 +0000	Cencora (COR) Valuation Check as Logistics Expansion and Earnings Upgrades Fuel Investor Interest Cencora (COR) is back on investors radar after unveiling major upgrades to its third party and specialty logistics network in the United States and Europe, moves that neatly reinforce its improving earnings outlook. See our latest analysis for Cencora. The latest logistics expansion comes on the back of strong momentum, with a year to date share price return of 53.29% and a five year total shareholder return of 268.75%, suggesting investors are steadily repricing Cencora’s growth and...
Wed, 10 Dec 2025 13:59:00 +0000	Here's Why You Should Add Cencora Stock to Your Portfolio Now Cencora's U.S. Healthcare Solutions strength, RCA gains, and raised FY25 guidance underscore its accelerating growth momentum.
Tue, 09 Dec 2025 14:40:04 +0000	Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? Here is how Cencora (COR) and CorMedix (CRMD) have performed compared to their sector so far this year.
Mon, 08 Dec 2025 04:33:57 +0000	1 S&P 500 Stock to Own for Decades and 2 That Underwhelm The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Fri, 05 Dec 2025 16:30:07 +0000	Why Is Cencora (COR) Down 6.3% Since Last Earnings Report? Cencora (COR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wed, 03 Dec 2025 20:26:18 +0000	Why Cencora (COR) Shares Are Trading Lower Today Shares of healthcare distributor Cencora (NYSE:COR) fell 4.3% in the afternoon session after analysts downgraded the company's stock to a "hold" rating from a "buy" a few days prior. This downgrade added to a negative trend for the stock, which had already fallen over the previous five trading sessions. The downward pressure from the new rating appeared to weigh on investor sentiment. The stock's performance reflected the market's reaction to the lowered expectations from the analyst firm.
Wed, 03 Dec 2025 19:59:00 +0000	JPMorgan Raises Cencora (COR) Price Target After Financial Model Update Cencora, Inc. (NYSE:COR) is included among the 15 Dividend Stocks that Outperform the S&P 500. On November 11, JP⁠Mor⁠gan raised its price t⁠arget on Cencora, Inc. (NYSE:COR) to $417 from $344 while mai‌ntaining an Overweight r‍ating, fo‌llowing an update to th⁠e comp⁠a⁠ny‌’s‌ f⁠inancial model. On November 5‌, Cencora, Inc. (NYSE:COR) announced pla‍ns to inves​t $1 […]
Wed, 03 Dec 2025 12:30:00 +0000	Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities CONSHOHOCKEN, Pa., December 03, 2025--Cencora, a global pharmaceutical solutions company, today announced investments to enhance its third-party logistics (3PL) capabilities in the United States and Europe, expanding its global network and strengthening the specialty logistics services it can deliver to pharmaceutical companies worldwide.
Wed, 03 Dec 2025 08:35:28 +0000	How Is Cencora’s Stock Performance Compared to Other Medical Stocks? While Cencora’s recent performance has lagged behind other healthcare stocks, analysts express strong confidence in its long-term growth potential.
Tue, 02 Dec 2025 17:00:04 +0000	Cencora (COR) Upgraded to Buy: Here's Why Cencora (COR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Mon, 01 Dec 2025 14:20:00 +0000	Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus MBX Biosciences' sharp rally highlights how Zacks' stock recommendations outpaced broader market gains across multiple portfolios.
Fri, 28 Nov 2025 12:08:00 +0000	CVS Health Delivers MBR Improvement: Is More Progress in the Cards? CVS posts a sharper MBR as PDR impacts ease and government business strengthens while maintaining a cautious full-year outlook.
Thu, 27 Nov 2025 22:10:36 +0000	How Investors Are Reacting To Cencora (COR) Expanding Global Reach With Alliance Healthcare Acquisition On November 25, 2025, Cencora Inc filed its annual 10-K report, detailing substantial financial growth and highlighting its acquisition of Alliance Healthcare to strengthen its global pharmaceutical distribution capabilities. The report also underscored Cencora's expanding opportunities in international markets and specialty pharmaceuticals, while noting increased operating expenses and ongoing litigation risks as important challenges. We'll now explore how Cencora's expanded international...
Thu, 27 Nov 2025 20:08:59 +0000	Should You Take Another Look at Cencora After a 64% Rally in 2025? Curious if Cencora stock still offers good value or if recent gains have pushed it out of reach? You are not alone in wondering whether now is the right time to take a closer look. Shares have been on the move, rising 2.2% in the past week and 64.0% year-to-date, building on an impressive 277.7% gain over the last five years. Recent headlines have highlighted Cencora’s expansive strategies, including major partnerships and sector-leading initiatives. These developments are fueling fresh...
Thu, 27 Nov 2025 15:13:00 +0000	A Fresh Look at Cencora (COR) Valuation Following Its Recent Share Price Momentum Cencora (COR) has shown a steady performance in recent weeks, catching the attention of investors who are watching for shifts in the healthcare distribution space. The stock’s trajectory offers an interesting lens into ongoing sector trends. See our latest analysis for Cencora. Cencora’s latest share price of $368.53 caps off an impressive run, with a 9.7% 1-month share price return and momentum continuing to build after recent sector tailwinds. Over the last year, shareholders enjoyed a...
Wed, 26 Nov 2025 14:09:00 +0000	GEHC Stock Gains Post Latest Launch to Optimize Radiology Workflows GE HealthCare unveils Genesis Radiology Workspace, aiming to streamline imaging workflows and boost diagnostic precision.
Mon, 24 Nov 2025 14:15:03 +0000	Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Fri, 21 Nov 2025 14:40:02 +0000	Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? Here is how Cencora (COR) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Tue, 18 Nov 2025 14:15:04 +0000	Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue? Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!